Development and Assessment of Non-Infected and Infected Skin Models Using MALDI-MSI
Poster Nov 21, 2017
E. E. L. Lewis, M. R. T. Barrett, D. Caballero-Lima, R. A. Bojar and M. R. Clench
Infections are known to have a detrimental effect on wound healing leading to chronic would formation. Chronic wounds are becoming a burden for western societies due to increased incidences of obesity, diabetes and ageing populations. This health crisis has a vast effect on wound care management resources and budgets worldwide. Effective diagnosis and wound management has been shown to reduce costs and chronic wound formation. Therefore it is vital to understand the molecular mechanisms involved in the wound healing process. Labskin is a human living skin equivalent model (LSE), which when used in combination with Mass Spectrometry Imaging (MSI) is able to assess biological changes within non-infected and infected wounds to identify biomarkers associated with wound healing. Here we report the development of a novel incision method for wounding LSE: infection of these wounds and their study by MALDI-MSI.
Depressive Symptoms Related to Biological Markers of Immune Functioning among Young People with HIVPoster
Youth living with HIV (YLWH) are at risk for depression. This study aimed to identify trends in depressive symptoms for YLWH in a specialty-care clinic and follow up clinical treatment procedures.READ MORE
Histone Deacetylase 6 (HDAC6) As A Therapeutic Target in Chronic Lymphocytic LeukemiaPoster
This study investigates the role of histone deacetylase 6 (HDAC6) in chronic lymphocytic leukemia and establishes it as a novel therapeutic target for the treatment of this disease.READ MORE
Inhibition of The Auto-inflammation Suppressor Protein ISG15 Triggers Preeclampsia by Blocking Trophoblast Migration and InvasionPoster
In summary, ISG15 expression levels are crucial for trophoblast morphology and function (migration/invasion). By blocking trophoblast invasion, reduced ISG15 levels could contribute to impaired spiral artery transformation that reduces utero-placental blood flow in preeclampsia. Thus, agents inducing ISG15 expression are likely to be therapeutic in preeclampsia.